A new federal amendment will ban hemp-derived THC products exceeding 0.4 mg THC per container, effectively eliminating the intoxicating hemp category. The rule will reshape the $28 billion hemp-THC industry and force businesses to prepare for major operational changes.

The New York Medical Cannabis Industry Association has filed a lawsuit against state regulators, claiming mismanagement allowed illicit cannabis to overrun the market. The case could force major changes in enforcement and reshape the state’s cannabis industry.

The new government-funding deal includes a provision limiting hemp-derived THC beverages to just 0.4 mg of THC per serving — effectively dismantling the booming low-dose beverage category. Companies that scaled in this space now face reformulation, revenue loss, and major regulatory challenges.

Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.

A proposed federal spending bill includes language that could ban most ingestible hemp-derived THC products, threatening an estimated $28 billion industry. The measure would eliminate Delta-8, THCA, and other intoxicating hemp items — reshaping the national marketplace overnight.

Governor Newsom’s signing of AB 8 officially merges intoxicating hemp products into California’s regulated cannabis system. The new law enforces parity, closes long-standing loopholes, and establishes a single, safer standard for both markets.